ConductScience.org, home

Paper6344762

Falciparum malaria: the urgent need for safe and effective drugs.

Rieckmann KH. Annu Rev Med, 1983. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Falciparum malaria: the urgent need for safe and effective drugs. Papers, record 6344762. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6344762

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Falciparum malaria: the urgent need for safe and effective drugs.
PubMed
Journal
Annu Rev Med
PubMed
Year
1983
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
0.94
iCite
Revised in PubMed
2013-11-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rieckmann KHK H

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntimalarialsMajor topic
MalariaMajor topic
Amodiaquine
Anti-Bacterial Agents
Dapsone
Drug Combinations
Humans
Plasmodium falciparum
Pyrimethamine
Quinidine
Quinine
Sulfadoxine

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
31451506Kinetic Driver of Antibacterial Drugs against Plasmodium falciparum and Implications for Clinical Dosing.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/31451506PubMed
17876000Pharmacodynamics of doxycycline in a murine malaria model.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17876000PubMed
9517961The antibiotic micrococcin is a potent inhibitor of growth and protein synthesis in the malaria parasite.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9517961PubMed
6150865Malaria prophylaxis in travellers: the current position.Experientia1984https://conductscience.org/library/papers/6150865PubMed
3542831Inhibition of malaria parasite invasion of human erythrocytes by a lymphocyte membrane polypeptide.Infect Immun1987https://conductscience.org/library/papers/3542831PubMed
3524430Quaternary ammonium compounds efficiently inhibit Plasmodium falciparum growth in vitro by impairment of choline transport.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3524430PubMed
2201255In vitro susceptibilities of Plasmodium falciparum to compounds which inhibit nucleotide metabolism.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2201255PubMed
1503432Molecular targets of 5-fluoroorotate in the human malaria parasite, Plasmodium falciparum.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1503432PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6344762

GET https://conductscience.org/api/papers/v1/6344762/authors